As of Jun 29
| -0.38 / -2.29%|
The 4 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 20.00, with a high estimate of 22.00 and a low estimate of 18.00. The median estimate represents a +23.30% increase from the last price of 16.22.
The current consensus among 4 polled investment analysts is to Buy stock in AngioDynamics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.